ATE331533T1 - Pharmazeutische zusammensetzungen von hedgehog- proteinen und deren verwendung - Google Patents
Pharmazeutische zusammensetzungen von hedgehog- proteinen und deren verwendungInfo
- Publication number
- ATE331533T1 ATE331533T1 AT99101642T AT99101642T ATE331533T1 AT E331533 T1 ATE331533 T1 AT E331533T1 AT 99101642 T AT99101642 T AT 99101642T AT 99101642 T AT99101642 T AT 99101642T AT E331533 T1 ATE331533 T1 AT E331533T1
- Authority
- AT
- Austria
- Prior art keywords
- carrier
- hedgehog protein
- hedgehog
- negatively
- binds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Marine Sciences & Fisheries (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98101893 | 1998-02-04 | ||
| EP98104416 | 1998-03-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE331533T1 true ATE331533T1 (de) | 2006-07-15 |
Family
ID=26149005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99101642T ATE331533T1 (de) | 1998-02-04 | 1999-02-04 | Pharmazeutische zusammensetzungen von hedgehog- proteinen und deren verwendung |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JP3092706B2 (de) |
| KR (2) | KR19990072406A (de) |
| CN (1) | CN1228994A (de) |
| AT (1) | ATE331533T1 (de) |
| AU (1) | AU713568B2 (de) |
| CA (1) | CA2260423C (de) |
| CZ (1) | CZ33799A3 (de) |
| DE (1) | DE69932113T2 (de) |
| HU (1) | HUP9900251A3 (de) |
| IL (1) | IL128329A (de) |
| MA (1) | MA26602A1 (de) |
| NO (1) | NO990471L (de) |
| NZ (1) | NZ334065A (de) |
| SG (1) | SG66504A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW570805B (en) | 1998-09-01 | 2004-01-11 | Hoffmann La Roche | Water-soluble pharmaceutical composition in an ionic complex |
| KR100452752B1 (ko) * | 2000-04-18 | 2004-10-12 | 주식회사 펩트론 | 단백질 함유 서방성 제제를 제조하는 방법 및 그 제제 |
| KR101705323B1 (ko) * | 2010-03-23 | 2017-02-13 | 코웨이 주식회사 | 역삼투막 방식의 정수기 |
| CN102174794B (zh) * | 2011-03-07 | 2012-08-15 | 江苏科技大学 | 一种六点支撑架桥作业平台自动调平系统及方法 |
| KR102176832B1 (ko) * | 2017-11-29 | 2020-11-10 | 주식회사 파이안바이오테크놀로지 | 헤지호그 단백질 및 생체 적합성 물질을 포함하는 미세 입자 및 이를 포함하는 탈모 예방 또는 치료용 조성물 |
-
1999
- 1999-01-28 CA CA002260423A patent/CA2260423C/en not_active Expired - Fee Related
- 1999-02-01 MA MA25446A patent/MA26602A1/fr unknown
- 1999-02-01 NO NO990471A patent/NO990471L/no unknown
- 1999-02-01 CZ CZ99337A patent/CZ33799A3/cs unknown
- 1999-02-02 IL IL12832999A patent/IL128329A/xx active IP Right Grant
- 1999-02-03 HU HU9900251A patent/HUP9900251A3/hu unknown
- 1999-02-03 SG SG1999000333A patent/SG66504A1/en unknown
- 1999-02-04 DE DE69932113T patent/DE69932113T2/de not_active Expired - Fee Related
- 1999-02-04 AT AT99101642T patent/ATE331533T1/de not_active IP Right Cessation
- 1999-02-04 NZ NZ334065A patent/NZ334065A/en unknown
- 1999-02-04 JP JP11027836A patent/JP3092706B2/ja not_active Expired - Fee Related
- 1999-02-04 KR KR1019990003669A patent/KR19990072406A/ko active Search and Examination
- 1999-02-04 CN CN99101764A patent/CN1228994A/zh active Pending
- 1999-02-04 KR KR1019990003759A patent/KR100311565B1/ko not_active IP Right Cessation
- 1999-02-04 AU AU15426/99A patent/AU713568B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| KR100311565B1 (ko) | 2001-11-02 |
| CZ33799A3 (cs) | 1999-08-11 |
| SG66504A1 (en) | 2000-07-18 |
| HUP9900251A2 (hu) | 1999-09-28 |
| HUP9900251A3 (en) | 2001-01-29 |
| MA26602A1 (fr) | 2004-12-20 |
| JP3092706B2 (ja) | 2000-09-25 |
| CA2260423A1 (en) | 1999-08-04 |
| JP2000119193A (ja) | 2000-04-25 |
| KR19990072423A (ko) | 1999-09-27 |
| IL128329A (en) | 2005-08-31 |
| AU1542699A (en) | 1999-08-26 |
| DE69932113T2 (de) | 2007-01-25 |
| NO990471L (no) | 1999-08-05 |
| AU713568B2 (en) | 1999-12-02 |
| IL128329A0 (en) | 2000-01-31 |
| CN1228994A (zh) | 1999-09-22 |
| CA2260423C (en) | 2006-06-20 |
| NZ334065A (en) | 2000-06-23 |
| HU9900251D0 (en) | 1999-03-29 |
| DE69932113D1 (de) | 2006-08-10 |
| NO990471D0 (no) | 1999-02-01 |
| KR19990072406A (ko) | 1999-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE252919T1 (de) | Zusammensetzungen und ihre verwendung zur verhütung von verklebungen zwischen körpergewebe | |
| CA2291074A1 (en) | Composition and method for enhancing transport across biological membranes | |
| WO2003068144A3 (en) | Cytotoxic agents | |
| CA2239775A1 (en) | Crosslinked polymer compositions and methods for their use | |
| JP2003525916A5 (de) | ||
| DE69922189D1 (de) | Pharmazeutische zusammensetzungen enthaltend faktor viii und neutrale liposomen | |
| EA200000331A1 (ru) | Фармацевтические композиции, содержащие белок плазмы | |
| CA2371462A1 (en) | Modified protein matrices | |
| PT814827E (pt) | Factor de crescimento vascular endotelial-b | |
| TR200101751T2 (tr) | Poliol-IFN-beta konjugatları | |
| AU3822497A (en) | Temperature sensitive gel for sustained delivery of protein drugs | |
| AR014940A1 (es) | Un portador para la liberacion de un agente bioactivo, un polimero poliester biodegradable, copolimeros y composiciones farmaceuticas que loscontienen. | |
| ATE332918T1 (de) | Neoglycoproteine | |
| Takaoka et al. | Bone regeneration by lactoferrin released from a gelatin hydrogel | |
| DE60334388D1 (de) | Blockcopolymer-mizellenzusammensetzung mit verbesserter arzneimittelbeladungskapazität und verzögerter freisetzung | |
| ATE267854T1 (de) | Materialen aus polymermischungen auf basis von zwitterionischem polymer | |
| DE69819145D1 (de) | Bioabbaubare mikropartikeln mit verzögerter wirkstofffreisetzung | |
| ATE331533T1 (de) | Pharmazeutische zusammensetzungen von hedgehog- proteinen und deren verwendung | |
| CA2407952A1 (en) | Growth factor modified protein matrices for tissue engineering | |
| ATE291929T1 (de) | Zusammensetzungen zur abgabe von biologischen wirkstoffen und verfahren zu ihrer herstellung | |
| CO4810246A1 (es) | Polipeptidos modificados con alta actividad y alergenicidad reducida | |
| WO1996028468A3 (en) | Amphiphilic peptide and analogs thereof | |
| WO1991003226A3 (en) | Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same | |
| ES2153648T3 (es) | Polimeros con estado fisico y bioerosionabilidad controlados. | |
| ECSP992851A (es) | Composiciones farmaceuticas de proteinas erizo y uso de las mismas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |